Stock·NASDAQ·Technology
Cerebras Systems Inc. (CBRS)
- Market cap
- $25.74B
- Dividend yield
- None
- Street target
- $300.00median of 11 analysts
- 52-week range
- $106.13 $386.34
CBRS stock forecast today
Where CBRS stands today, and what CleaRank Financial AI makes of it.
CBRS at a glance
Cerebras Systems Inc. (CBRS): Hold, 55/100 on CleaRank's AI score.
- Insiders Insiders sold $408.4M and made no open-market purchases over the last 18 months.
Figures as of October 26, 2026.
CleaRank Financial AI
CBRS, Cerebras Systems Inc., receives a Hold rating from CleaRank with a model score of 55/100.
The analysts' outlook contributes the most to that score: 11 of 11 analysts rate the stock a buy, and the median target is 176.8% above the price. Valuation pulls the score down the most.
Only on CleaRank
Figures we compute ourselves from CBRS's own price, earnings and insider-filing history. Tap one to see it in context.
CBRS stock price and trading
The chart, today's range and how far the price has moved over each period.
CBRS share price
Pick a period: each tab shows how far CBRS has moved over it, to the last close.
Today's trading
Where CBRS sits inside today's range and its 52-week range.
CBRS fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
0/2P/S below the sector median ›
The price-to-sales ratio of 37.82 is 397.6% above the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was -$487.2M on revenue of $680.7M, a net margin of -71.6%.
Key statistics
The headline figures for CBRS.
As of October 26, 2026, CBRS trades at $108.37, with a market value of $25.74B.
What the numbers say
CleaRank Financial AI's reading of CBRS's valuation, growth and risks.
Measured on sales instead, the stock changes hands at 37.82 times revenue, a multiple that sits 397.6% above the sector median of 7.6.
The company is losing money, with a net margin of -71.6% and an operating margin of -264.97%. Shareholders' capital earns -15.19%, below the sector median of 13.4%, measured as return on equity. The balance sheet rounds out the picture, with debt-to-equity of 0.16.
CBRS posted -$0.05 a share in its latest report, dated August 12, 2026, compared with an analyst estimate of -$0.18, so the result was better than expected. The share price nonetheless dropped 11.85% in the first session after the release.
CBRS has beaten estimates in 2 of the last 2 reports, yet the share price fell in the first session after each of those 2 beats. The biggest earlier reaction followed the June 23, 2026 report: EPS beat the estimate by 73.33%, but the stock fell 19.61%. For the future, analysts forecast EPS of -$0.47 for this fiscal year and $1.27 for the next.
Daily swings are the main risk to plan for, since CBRS typically moves 4.42% on an average session. The price is 71.95% below the 52-week high of $386.34. Over the last 18 months insiders disposed of $408.4M in stock and made no open-market purchases. Such sales are frequently scheduled ahead of time or tied to tax on vesting shares, so they carry less weight than buying would.
CBRS against the Technology sector
How CBRS compares with the median Technology stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, CBRS trades at 37.82x, far above the sector average of 7.60x.
Return vs XLK: Since May 14, 2026, CBRS has lost 65.2% against a gain of 3.8% for XLK.
Performance against XLK
CBRS and the Technology sector fund over the same days.
Revenue and earnings
How much CBRS sells, and how much of it becomes profit.
The quarterly bars end with Q1 '26 (the quarter to March 31, 2026); CBRS reported again on August 12, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 75.7% in FY2025 to $510M, from $290M a year earlier.
Profit margin: The net margin was 46.6% in FY2025, up from -165.9% the year before.
Profitable: CBRS earned $238M in FY2025.
Earnings reality check
Did CBRS beat what analysts expected, and how did the stock react?
Earnings record: CBRS beat the analyst estimate in 2 of the last 2 quarters.
Market reaction: The stock fell in the first session after 2 of those 2 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 12, 2026after close | -$0.18 | -$0.05 | +72.22% | -11.85% | -17.69% |
| Jun 23, 2026after close | -$0.15 | -$0.04 | +73.33% | -19.61% | -2.52% |
As of October 26, 2026, CBRS has beaten the analyst EPS estimate in 2 of its last 2 reported quarters and fell in the first trading session after 2 of those beats; its latest report, on August 12, 2026, came in 72.22% above the estimate and the stock moved -11.85% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
CBRS AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
0/3RSI not overbought or oversold ›
The 14-day RSI is 23.0, in oversold territory.RSI above 50 ›
An RSI of 23.0 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of CBRS
The score, the reasoning behind it, and what could move the price next.
CBRS trades close to the floor of its 52-week range. The price is 2.11% above the $106.13 low and 71.95% below the $386.34 high.
Momentum is weak for CBRS: the 14-day RSI of 23.0 places it in oversold territory, and the MACD line is negative. Over the past week the price fell 10.19%, over the past month it fell 47.58%, and over the past three months it fell 42.54%.
Analyst upgrade ›
Freedom Capital Markets upgraded it to Buy from Hold on October 2, 2026.
Source: Analyst action, Freedom Capital Markets, October 2, 2026Rating reaffirmed ›
TD Cowen kept its Buy rating on October 19, 2026.
Source: Analyst action, TD Cowen, October 19, 2026
Earnings beat, but the stock fell ›
The August 12, 2026 report beat the EPS estimate by 72.22%, and the share price fell 11.85% in the first session after it.
Source: Earnings report, August 12, 2026
- Keep an eye on the two nearest levels: the 20-day EMA at $142.72 sits above the price, and the 52-week low at $106.13 sits below it.
- A 14-day RSI of 23.0 places CBRS in the oversold zone, and the MACD line is negative. Readings above 70 or below 30 are generally treated as signs of stretched momentum.
- CBRS beat estimates in 2 of the last 2 reports. After the August 12, 2026 report, the share price fell 11.85% in the first session.
For CBRS, the closest levels are the 20-day EMA at $142.72 above the price and the 52-week low at $106.13 below it.
Momentum is washed out, with the RSI below the oversold line; a turn back above it would be an early sign of stabilising.
Technical indicators
Momentum and trend for CBRS, from its daily closes.
As of October 26, 2026, with CBRS at $108.37, its 14-day RSI is 23.0 (oversold territory) and its 50-day simple moving average is $177.64.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What CBRS moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, CBRS's 1-year correlation of daily returns is +0.31 with S&P 500 (SPY), +0.40 with Nasdaq 100 (QQQ), +0.20 with Bitcoin (BTC) and +0.18 with gold (XAU).
CBRS price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
11 of 11 analysts rate it a buy or strong buy, 0 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $300.00 is 176.8% above the price.More buy ratings than three months ago ›
11 of 11 rate it a buy now, against 10 of 11 three months ago.
CBRS Wall Street View
12-month price targets
The price, $108.37, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 19, 2026 | TD Cowen | Maintains | Buy |
| Oct 2, 2026 | Freedom Capital Markets | Upgrade | Buy |
| Sep 14, 2026 | Freedom Capital Markets | Maintains | Hold |
| Aug 19, 2026 | Rosenblatt | Maintains | Buy |
| Aug 19, 2026 | Needham | Reiterates | Buy |
| Aug 13, 2026 | UBS | Maintains | Buy |
As of October 26, 2026, 11 Wall Street analysts cover CBRS: 11 rate it a buy or strong buy, 0 a hold and 0 a sell or strong sell. Their 12-month price targets range from $175.00 to $330.00. The median CBRS price target is $300.00, 176.8% above the price of $108.37.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
CBRS trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
CBRS trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
CBRS moves about 4.4% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much CBRS tends to move, against the market and on its own.
CBRS price history and drawdowns
CBRS's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/2Average daily move under 2% ›
The price has moved 4.42% on an average day (30-day standard deviation of daily returns).Beat the S&P 500 since the chart begins ›
$10,000 invested in May 2026 is now worth $3,484, against $10,282 in the S&P 500 (SPY).
Growth of $10,000
What $10,000 put into CBRS in May 2026 is worth now, against the same amount in the S&P 500.
Against the market: CBRS trailed the S&P 500 over this period: $3,483.78 against $10,282.
A $10,000 investment in CBRS in May 2026 would be worth about $3,484 today with dividends reinvested, compared with about $10,282 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
CBRS long-term price scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
CBRS Stock Price Prediction
CBRS has less than a year of price history, too little for a long-range projection, so CleaRank shows no multi-year price table yet. It appears here once a full year of history is available.
CBRS insider trading
What the people running the company have bought and sold.
CBRS insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought CBRS shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 26, 2026, CBRS insiders reported 22 open-market sales worth $408.4M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 29, 2026 | Dhiraj Mallick
Chief Operating Officer
|
Sell | 396.0K | $80.8M |
| Sep 29, 2026 | Robert Patrick Komin Jr
Chief Financial Officer
|
Sell | 32.5K | $6.6M |
| Sep 29, 2026 | Dhiraj Mallick
Chief Operating Officer
|
Grant | 276.0K | - |
| Sep 28, 2026 | Yagnesh Patel
Officer
|
Sell | 1.3K | $269.9K |
| Sep 25, 2026 | Sean Lie
Chief Technology Officer
|
Sell | 120.0K | $25.1M |
| Sep 25, 2026 | Sean Lie
Chief Technology Officer
|
Grant | 36.0K | - |
| Sep 25, 2026 | Sean Lie
Chief Technology Officer
|
Grant | 120.0K | - |
| Sep 4, 2026 | Sean Lie
Chief Technology Officer
|
Sell | 53.5K | $11.2M |
| Sep 4, 2026 | Steven Vassallo
Director
|
Sell | 50.0K | $10.5M |
| Sep 4, 2026 | Andrew D Feldman
Chief Executive Officer
|
Sell | 37.4K | $7.9M |
| Sep 4, 2026 | Andrew D Feldman
Chief Executive Officer
|
Grant | 37.4K | - |
| Sep 4, 2026 | Sean Lie
Chief Technology Officer
|
Grant | 46.1K | - |
| Sep 4, 2026 | Sean Lie
Chief Technology Officer
|
Grant | 16.0K | - |
| Aug 24, 2026 | Benchmark Capital Management Co. Viii, L.L.C.
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 963.8K | - |
| Aug 21, 2026 | Sean Lie
Chief Technology Officer
|
Sell | 726.5K | $151.1M |
| Aug 21, 2026 | Andrew D Feldman
Chief Executive Officer
|
Sell | 237.6K | $47.3M |
| Aug 21, 2026 | Andrew D Feldman
Chief Executive Officer
|
Grant | 237.6K | - |
| Aug 21, 2026 | Andrew D Feldman
Chief Executive Officer
|
Grant | 50.0K | - |
| Aug 21, 2026 | Foundation Capital Management Co. Viii, L.L.C
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 1.2M | - |
| Aug 21, 2026 | Sean Lie
Chief Technology Officer
|
Grant | 713.1K | - |
| Aug 21, 2026 | Steven Vassallo
Director
|
Grant | 1.2M | - |
| Aug 20, 2026 | Sean Lie
Chief Technology Officer
|
Grant | 213.1K | - |
| Aug 18, 2026 | Dhiraj Mallick
Chief Operating Officer
|
Sell | 38.9K | $8.6M |
| Aug 18, 2026 | Andrew D Feldman
Chief Executive Officer
|
Sell | 26.6K | $5.9M |
| Aug 18, 2026 | Sean Lie
Chief Technology Officer
|
Sell | 21.3K | $4.7M |
| Aug 18, 2026 | Yagnesh Patel
Officer
|
Sell | 4.6K | $1.0M |
| Aug 18, 2026 | Andrew D Feldman
Chief Executive Officer
|
Grant | 93.5K | - |
| Aug 18, 2026 | Foundation Capital Management Co. Viii, L.L.C
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 1.9M | - |
| Aug 18, 2026 | Robert Patrick Komin Jr
Chief Financial Officer
|
Grant | 32.5K | - |
| Aug 18, 2026 | Sean Lie
Chief Technology Officer
|
Grant | 616.7K | - |
| Aug 18, 2026 | Dhiraj Mallick
Chief Operating Officer
|
Grant | 158.9K | - |
| Aug 18, 2026 | Yagnesh Patel
Officer
|
Grant | 6.3K | - |
| Aug 18, 2026 | Steven Vassallo
Director
|
Grant | 1.9M | - |
| Aug 17, 2026 | Eric Vishria
Director
|
Sell | 68.3K | $15.7M |
| Aug 17, 2026 | Benchmark Capital Management Co. Viii, L.L.C.
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 2.4M | - |
| Aug 14, 2026 | Steven Vassallo
Director
|
Sell | 50.0K | $10.9M |
| Aug 14, 2026 | Foundation Capital Management Co. Viii, L.L.C
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 1.9M | - |
| Aug 14, 2026 | Steven Vassallo
Director
|
Grant | 1.9M | - |
| Jun 30, 2026 | Dhiraj Mallick
Chief Operating Officer
|
Sell | 10.0K | $2.1M |
| Jun 30, 2026 | Dhiraj Mallick
Chief Operating Officer
|
Grant | 10.0K | - |
| Jun 29, 2026 | Benchmark Capital Management Co. Viii, L.L.C.
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 2.2M | - |
| Jun 26, 2026 | Dhiraj Mallick
Chief Operating Officer
|
Sell | 33.3K | $5.9M |
| Jun 26, 2026 | Yagnesh Patel
Officer
|
Sell | 4.0K | $696.8K |
| Jun 26, 2026 | Yagnesh Patel
Officer
|
Grant | 15.0K | - |
| Jun 25, 2026 | Dhiraj Mallick
Chief Operating Officer
|
Sell | 36.1K | $6.1M |
| Jun 25, 2026 | Andrew D Feldman
Chief Executive Officer
|
Sell | 18.0K | $3.1M |
| Jun 25, 2026 | Sean Lie
Chief Technology Officer
|
Sell | 10.0K | $1.7M |
| Jun 25, 2026 | Yagnesh Patel
Officer
|
Sell | 6.1K | $1.0M |
| Jun 25, 2026 | Andrew D Feldman
Chief Executive Officer
|
Grant | 18.0K | - |
| Jun 25, 2026 | Sean Lie
Chief Technology Officer
|
Grant | 10.0K | - |
| Jun 25, 2026 | Dhiraj Mallick
Chief Operating Officer
|
Grant | 69.4K | - |
| Jun 25, 2026 | Yagnesh Patel
Officer
|
Grant | 10.1K | - |
| Jun 11, 2026 | Lior Susan
Director
|
Grant | 13.5M | - |
| May 15, 2026 | Benchmark Ai Infrastructure Management Co., L.L.C
Beneficial Owner of more than 10% of a Class of Security
|
Option | 2.5M | $707.0M |
| May 15, 2026 | Benchmark Capital Management Co. Viii, L.L.C.
Beneficial Owner of more than 10% of a Class of Security
|
Option | 14.4M | $4.0B |
| May 15, 2026 | Foundation Capital Management Co. Viii, L.L.C
Beneficial Owner of more than 10% of a Class of Security
|
Option | 13.9M | $3.9B |
| May 15, 2026 | Steven Vassallo
Director
|
Option | 12.6M | $3.5B |
Source: TwelveData, from SEC Form 4 filings
CBRS stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.